BIRC2 and thyroid gland carcinoma: BRAFV600E could increase the carcinogenicity of thyroid cancer cells through NF-κB mediated c-IAP1, c-IAP2, and XIAP, thus increasing the invasiveness of thyroid cancer cells [123, 124].